• Foundation Medicine Announces $42.5m in Series B Financing

    Boston Globe |  Foundation Medicine announced a $42.5 million Series B financing round this morning thanks to Deerfield Management Company, L.P., Casdin Capital, Redmile Group and strategic investors Roche Venture Fund and WuXi Corporate Venture Fund.

    Sep 20, 2012

  • New Pharma Collaboration Focuses on Clinical Standards

    Bio-IT World | A new big pharma collaboration has been launched to identify and solve common drug development challenges, starting with clinical study execution. TransCelerate BioPharma was created by ten companies—Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech (a member of the Roche Group), and Sanofi—all of which have pooled financial, personnel, and other resources to solve industry-wide challenges in a collaborative environment. 

    Sep 19, 2012

  • Illumina Acquires Cytogenetics Company BlueGnome

    BlueGnome | Illumina today announced that it will acquire UK company BlueGnome, a cytogenetics company that looks at the structure and function of cells for genetic abnormalities. 

    Sep 19, 2012

  • The Genomics Guinea Pigs

    NPR | The researchers who are serving as genomics guinea pigs are also working through how we should process the information the genome reveals.

    Sep 19, 2012

  • Genomic Applications for All

    23andMe | 23andMe has released their API to allow developers to design new applications and tools for the 23andMe community accessing 23andMe data.

    Sep 18, 2012

  • Firms Charge Fiduciary Breach in BGI-Complete Merger

    Bio-IT World | The announcement on Monday that Complete Genomics will be acquired by BGI for $117.6 million has left many surprised and dismayed. A slew of firms have announced investigations of the Complete Genomics Board of Directors contending that the $3.15/share price may not be "fair". 

    Sep 18, 2012

  • Biotech Making Friends with Twitter

    Xconomy | Biotech comes into its own on Twitter. Luke Timmerman of Xconomy discusses the advantages for the industry.

    Sep 18, 2012

  • Craigslist Helps Reveal Flu Antibody

    UT San Diego | Researchers from the Scripps Research Institute in La Jolla and Sea Lane Biotechnologies have identified an antibody that protects cells from the influenza virus with the help of Craigslist donors.

    Sep 17, 2012

  • Pharma Turns to Second Generation Emerging Markets

    GlobalData | Sanofi is looking past the BRIC countries--Brazil, Russia, India, China--at other emerging markets, singling out Columbia, Indonesia, and Vietnam for future growth. 

    Sep 17, 2012

  • Sequencing Giants BGI and Complete Genomics Announce Merger Agreement

    Bio-IT World | In a stunning move for the genomics industry, two leading DNA sequencing service providers – China’s BGI and Complete Genomics – have entered into a definitive merger agreement valued at $117 million.  

    Sep 17, 2012

  • Panasas Launches Combo Flash Storage

    Bio-IT World | Panasas today announced an update to its parallel storage system: ActiveStor 14, the first product in the industry to use flash memory and an intelligent storage layout for mixed workloads, Geoffrey Noer, senior director of product marketing, tells Bio-IT World.  

    Sep 14, 2012

  • Supercomputing the Resistome

    TACC | Nobel laureate Bruce Beutler is using the supercomputing resources at  the Texas Advanced Computing Center (TACC) at The University of Texas at Austin to sequence the exomes of 8,000 mice in order to identify the mammalian "resistome".

    Sep 14, 2012

  • PerkinElmer Acquires R&D Rights to TIBCO Software

    Boston Globe | PerkinElmer has acquired exclusive rights to TIBCO Software's data analysis software in scientific research and development markets. 

    Sep 14, 2012

  • Sequencing Studies Take on Lung Cancer

    Nature News | Three sequencing studies published this week take on lung cancer, laying the groundwork for more effective personalized treatment. The studies looked at a combined 361 patients with different types of lung cancers and an additional 17 tumors.

    Sep 14, 2012

  • Boehringer Ingelheim Launches Pharma Facebook Game

    PSFK | Boehringer Ingelheim has developed a Facebook game called Syrum. The health of the world is in the user's hands, and players can collaborate with others to save it.

    Sep 13, 2012

  • Clouds, Supercomputing Shine at Bio-IT World Cloud Summit

    Bio-IT World | SAN FRANCISCO—A variety of cloud computing and supercomputing resources and applications shone brightly at the Bio-IT World Cloud Summit* in San Francisco this week.  

    Sep 13, 2012

  • HHMI Awards Three Interdisciplinary Grants

    HHMI | HHMI has awarded three grants to develop interdisciplinary graduate training programs that integrate the biomedical sciences with the physical sciences and engineering, as part of its Interfaces Initiative.

    Sep 13, 2012

  • SABs for Biotech Startups

    Forbes | For early biotechs, a scientific advisory board can provide an objective, external perspective and quality authentication, but they can also be expensive and create challenges. 

    Sep 12, 2012

  • X Prize Launches Open Bioinformatics Challenge

    Bio-IT World | The Archon Genomics X Prize is launching a Bioinformatics Challenge tomorrow morning at 9:00 PST. The challenge is offering a $2,500 prize for the “most impactful, most material” improvements to the validation protocol and software for the X Prize said Grant Campany, senior director & prize lead, Archon Genomics X PRIZE presented by Express Scripts.

    Sep 11, 2012

  • Illumina Launches Fast Clinical Sequencing, Data Sets, Clinical Alliance

    Bio-IT World News Brief | Illumina announced several advancements in clinical genomic sequencing today including Individual Genome Sequencing (IGS) service, a strategic alliance with Partners HealthCare, and five content sets to provide comprehensive evaluation of genes associated with specific disease area.   

    Sep 11, 2012